Zurcher Kantonalbank (Zurich Cantonalbank) - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274,294
+17.8%
9,949
+28.4%
0.00%0.0%
Q2 2023$232,845
-2.5%
7,746
+17.5%
0.00%0.0%
Q1 2023$238,901
-9.7%
6,594
-11.1%
0.00%0.0%
Q4 2022$264,600
-11.5%
7,418
-16.0%
0.00%
-50.0%
Q3 2022$299,000
+17.3%
8,8270.0%0.00%
+100.0%
Q2 2022$255,000
-11.5%
8,827
-1.0%
0.00%0.0%
Q1 2022$288,000
-5.6%
8,912
-14.9%
0.00%0.0%
Q4 2021$305,000
+88.3%
10,469
+72.8%
0.00%0.0%
Q3 2021$162,000
-13.4%
6,0600.0%0.00%0.0%
Q2 2021$187,000
+17.6%
6,0600.0%0.00%0.0%
Q1 2021$159,000
+4.6%
6,0600.0%0.00%0.0%
Q4 2020$152,000
+20.6%
6,0600.0%0.00%0.0%
Q3 2020$126,000
-12.5%
6,0600.0%0.00%0.0%
Q2 2020$144,000
+67.4%
6,060
+27.2%
0.00%0.0%
Q1 2020$86,000
+19.4%
4,765
+56.8%
0.00%0.0%
Q4 2019$72,000
-14.3%
3,0390.0%0.00%0.0%
Q3 2019$84,000
-16.8%
3,0390.0%0.00%0.0%
Q2 2019$101,000
-4.7%
3,0390.0%0.00%0.0%
Q1 2019$106,000
-15.2%
3,039
-19.1%
0.00%0.0%
Q4 2018$125,000
-33.9%
3,7560.0%0.00%
-50.0%
Q3 2018$189,000
-16.0%
3,7560.0%0.00%0.0%
Q2 2018$225,000
+37.2%
3,756
+5.2%
0.00%
+100.0%
Q1 2018$164,000
+15.5%
3,5720.0%0.00%0.0%
Q4 2017$142,000
+17.4%
3,572
+18.4%
0.00%0.0%
Q3 2017$121,000
-6.9%
3,0180.0%0.00%0.0%
Q2 2017$130,000
+420.0%
3,018
+278.2%
0.00%
Q1 2017$25,000
+25.0%
7980.0%0.00%
Q4 2016$20,0000.0%7980.0%0.00%
Q3 2016$20,000
+81.8%
798
+47.8%
0.00%
Q2 2016$11,000
+37.5%
5400.0%0.00%
Q1 2016$8,000
+14.3%
5400.0%0.00%
Q4 2015$7,000
-12.5%
5400.0%0.00%
Q3 2015$8,0005400.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 42,189$1,220,9500.03%
MASSMUTUAL TRUST CO FSB/ADV 320$9,2610.00%
Versant Capital Management, Inc 16$4630.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders